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ABSTRACT
The tumor microenvironment plays an important role in regulating cancer cell behavior.
The tumor microenvironment describes the cancer cells, and the surrounding endothelial cells,
fibroblasts, and mesenchymal stem cells, along with the extracellular matrix (ECM). The tumor
microenvironment stiffens as cancer undergoes malignant progression, providing biophysical cues
that promote invasive, metastatic cellular behaviors. This project investigated the influence of
three dimensional (3D) chitosan-alginate (CA) scaffold stiffness on the morphology, growth, and
migration of green fluorescent protein (GFP) – transfected MDA-MB-231 (231-GFP) breast
cancer (BCa) cells. The CA scaffolds were produced by the freeze casting method at three
concentrations, 2 wt%, 4 wt%, and 6 wt% to provide different stiffness culture substrates. The CA
scaffold material properties were characterized using scanning electron microscopy imaging for
pore structure and compression testing for Young’s Modulus. The BCa cell cultures were
characterized at day 1, 3, and 7 timepoints using Alamar Blue assay for cell number, fluorescence
imaging for cell morphology, and single-cell tracking for cell migration. Pore size calculations
using SEM imaging yielded pore sizes of 253.29 ± 52.45 µm, 209.55 ± 21.46 µm, and 216.83 ±
32.63 µm for 2 wt%, 4 wt%, and 6 wt%, respectively. Compression testing of the CA scaffolds
yielded Young’s Modulus values of 0.064 ± 0.008 kPa, 2.365 ± 0.32 kPa and 3.30 ± 0.415 kPa for
2 wt%, 4 wt%, and 6 wt% CA scaffolds, respectively. The results showed no significant difference
in cell number among the 3D CA scaffold groups. However, the 231-GFP cells cultured in 2 wt%
CA scaffolds possessed greater cellular size, area, perimeter, and lower cellular circularity
compared to those in 4 wt% and 6 wt% CA scaffolds, suggesting a more prominent presence of
cell clusters in softer substrates compared to stiffer substrates. The results also showed cells in 6
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wt% CA having a higher average cell migration speed compared to those in 2 wt% and 4 wt% CA
scaffolds, indicating a positive relationship between substrate stiffness and cell migration velocity.
Findings from this experiment may contribute to the development of enhanced in vitro 3D breast
tumor models for basic cancer research using 3D porous biomaterial scaffolds.
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CHAPTER ONE: INTRODUCTION
Background
Breast cancer (BCa) is the most commonly diagnosed cancer and the second leading cause
of death in women. Currently, many pharmaceutical companies utilize two dimensional (2D)
culture technologies for drug efficacy and toxicology assessments [1]. However, up to 95% of
promising preclinical drugs failed to translate into effective human cancer treatment [2]. One
reason for this high rate of failure may be explained by the disparity between the research
conducted in 2D cell culture environment and the clinical trials conducted in vivo in a three
dimensional (3D) environment [3]. The absence of the third dimension in a 2D culture limits the
communication between the cancer cells and its tumor microenvironment, affecting cell signaling,
vascularization, tumor progression, and metastasis [4]. In recent years, there has been a notable
increase in replacing 2D cultures with 3D biomaterials scaffolds for tissue culture in cancer
research. 3D scaffolds provide a more physiologically relevant model of the tumor
microenvironment compared to 2D surfaces by allowing 3D cell-cell and cell-material interaction
that lead to cellular behaviors more closely resembling physiological growth. Particular behaviors
include the slower cell growth in 3D cultures that mimic that of cells in vivo, and the development
of the hollow cores in 3D tumor cultures similar to necrotic areas deprived of nutrients and oxygen
in in vivo tumors [5]. The effects of scaffold materials on these interactions depend on its
mechanical properties such as stiffness, and chemical properties such as composition and presence
of proteins [6].
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Three Dimensional Biomaterial Scaffolds
In 1988, the term “tissue engineering” (TE) was coined, igniting a new interdisciplinary
field that aimed to regenerate damaged tissues by combining cells with 3D porous scaffolds and
growth factors [7]. In TE, 3D scaffolds are used as a template that provided the appropriate
structural support and environment for cells to adhere and grow, playing the role of a native
extracellular matrix (ECM) [7]. As cancer research expanded and the limitations of 2D culture
systems were realized, 3D cultures were adapted for use in cancer research, with 3D biomaterial
scaffolds being applied as a platform for 3D cultures [2].
Cancer cell morphology and behavior are dominated by the tumor microenvironment [8].
The tumor microenvironment describes the cancer cells, the surrounding endothelial cells,
fibroblasts, and the human mesenchymal stem cells that make up the heterogeneous tumor
population in vivo, and the ECM that serves as the structural support to the cells [9]. Development
of 3D cultures is ongoing to create more physiologically relevant 3D breast tumor models, with
research on 3D biomaterial scaffold modifications to optimize the growth of BCa cells [6]. These
modifications include, but are not limited to, choice of materials (synthetic or natural polymers),
porosity, and biochemical factors conjugation [2].
3D culture platforms with tunable mechanical properties must be developed to enable 3D
culture systems that may provide valuable in vivo predictions. BCa progresses as cells respond to
various cues from the microenvironment, changing from a benign phase into a more malignant and
invasive state [10]. These biophysical cues from the microenvironment include factors such as the
ECM stiffness, pore size, and fiber network [10]. The breast cancer metastatic progression has
been observed to occur with the tumor microenvironment transitioning from softer to stiffer tissue.
2

In a study investigating the elastic moduli of human breast tissue using cylindrical indenter and
finite element modelling, breast tissue stiffness ranged from 3.24 ± 0.61 kPa for normal
fibrograndular tissue to 42.52 ± 12.47 kPa for high-grade infiltrating ductal carcinoma (IDC) [11].
Breast Cancer Cell Lines
BCa is often classified based on the presence or absence of certain markers to aid in disease
prognosis and treatment plan determination. The three most common markers used in classification
are estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor
receptor 2 (HER-2) amplification. An example of a BCa cell line that is ER positive is the MCF-7
cells derived from metastatic pleural effusion of a 69-year-old Caucasian woman [12]. Examples
of BCa cell lines that are ER, PR, and HER-2 negative include MDA-MB-468 (468) and MDAMB-231 (231). 468 cells were derived from metastatic pleural effusion of a 51-year-old Black
woman, and 231 cells were derived from metastatic pleural effusion of a 51-year-old Caucasian
woman [13].
Breast tumors that lack all three of the molecular markers ER, PR, and HER-2 are called
triple-negative breast cancer (TNBC) tumors. TNBC is often diagnosed in female patients under
the age of 50, representing between 10% and 24% of BCa cases [14, 15]. TNBC has a high
tendency to metastasize and a higher risk for relapse compared to other types of BCa [15]. While
tumors that express ER and PR have promising prognosis with therapies that interfere with
hormone action or inhibit HER-2 amplification, TNBC tumors have less favorable prognosis due
to the lack of the markers [13].
One of the most commonly studied TNBC cell lines is the 231. 231 cells possess a 3D cell
morphology of a stellate pattern [16]. A comparison in gene expression between normal breast
3

cells and tumor cells indicated that 231 cells resemble basal cells on the outside of the breast ducts,
categorizing 231 cells as Basal B for molecular classification [13]. With this molecular
classification, 231 cell line has a clinical outcome worse than non-basal TNBC cell lines [17].
Cell Morphology in 3D Biomaterial Scaffolds
Cell surface receptors and actin cytoskeleton sense the stiffness of their microenvironment
and alter cell morphology and phenotype [5]. In 3D cultures, different subtypes of BCa cells show
different growth patterns. For example, 231 cells in 3D cultures show a stellate pattern, while 468
cells possess a grape cluster pattern [13]. When cultured in a 3D environment, BCa cells showed
cluster formation, as opposed to those cultured on a 2D surface, which showed a flat shape [18].
More specifically, the 231 2D cell growth has a spindle shape [8]. For 3D cultures in porous poly(εcaprolactone) (PCL) scaffold with stiffness similar to that of breast tumor tissue, 231 BCa cells
formed masses with 3D contact resembling the tumoroids in vivo [19].
One of the techniques used to characterize the BCa cell morphology include staining the
actin cytoskeleton with Alexa Fluor 546 or 488 Phalloidin, and counterstaining the nuclei with
4,6-diamidino-2-phenylindole (DAPI), then observing the cells using fluorescent microscopy [16,
18, 19]. Another technique is transfecting BCa cells with green fluorescent protein (GFP), which
allows GFP-transfected cells to be visualized with a fluorescence microscope [20]. Originally
extracted from the jellyfish Aequorea victoria in 1992, GFP labeling has been a widely used
protein marker.
Cell Growth in 3D Biomaterial Scaffolds
Since cells receive mechanical signals from their environment, it has been shown that
scaffold stiffness plays a role in affecting various cellular responses, including cell growth [21]. In
4

a study investigating the growth of 231 cells on 2D collagen-coupled polyacrylamide gels, it was
shown that cells significantly increased in number on the more rigid gels [22]. One possible
explanation for the increased 2D gel substrate stiffness leading to increased cell proliferation is
that 2D ECM stiffness quickens the cell cycle by influencing the mechanochemical feedback
during cell division [23]. However, when proliferation of MCF-7 BCa cells was compared between
3D alginate hydrogels with varied stiffness, the highest cell proliferation characterized by cell
cluster formation occurred in the softest 3D hydrogels with stiffness 150 - 200 kPa [18].
In addition to scaffold stiffness, diffusion of nutrients and growth factors also cause
differences in proliferation of cells cultured in 2D versus 3D environment [24]. While flat
monolayers of cells cultured on 2D surfaces readily receive oxygen and nutrients, spheroids of
cells in 3D environment show zones of proliferation due to oxygen and nutrient gradients [5].
Previous research has shown that the growth of tumor cells in 3D scaffolds is usually slower and
more closely resembling of the physiological growth than that in 2D surfaces [5].
Migration of Cells Cultured in 3D Biomaterial Scaffolds
Cell migration is a result of force combination involving the actin cytoskeleton, membrane
adhesions, and the ECM [25]. In a 3D environment, cell migration is characterized by traction
forces exerted by cell-ECM attachments over all surfaces of the cell adhered to the ECM [25]. It
has been demonstrated that matrix stiffness influences cell migration in 3D environments since
cells can sense the increased ECM stiffness through the transmembrane receptors that bind the
cells to their ECM or surrounding cells, and respond with increased traction force on their
environment using cytoskeletal networks and molecular motors [10, 26]. In a study investigating
how mechanical rigidity of the ECM regulates the behavior of glioma cells using time-lapse
5

imaging to monitor U373-MG and U87-MG cells over 12 h, it was found that the average
migration speed increased with increasing polyacrylamide gel substrate rigidity [23].
There are many techniques to characterize cell migration. One technique is taking timelapse images of 2D culture samples over a certain time period, and analyzing the images using
motion tracking or algorithms in software like SimplePCI [23]. Another is the Boyden Chamber
technique, where cells must degrade a collagen barrier to migrate from a non-serum-containing
media to a serum-containing media for a specified time period [19]. After this period, migrated
cells are stained and counted [19]. A more economical method is the scratch assay that introduces
an artificial gap, or scratch, on a confluent cell monolayer. Time-lapse images are captured at the
beginning and during the cell migration to close the gap to determine the migration rate [27].
Objectives
The quest for a BCa cure drives the need for improved 3D models that optimize the growth
of BCa cells by more accurately mimicking the native tumor microenvironment [6]. As the
mechanical properties of the ECM play a critical role in regulating cell behaviors, this research
project aims to understand how the mechanical properties of biomaterial scaffolds affect the
growth, morphology, and migration of BCa cells. Mechanical properties of the scaffolds,
particularly the stiffness, will be changed by preparing chitosan-alginate (CA) scaffolds with
different concentrations of chitosan and alginate, with greater concentrations leading to increased
stiffness. This study will include 2 wt%, 4 wt%, and 6 wt% 3D porous CA scaffolds. Tissue culture
polystyrene (TCPS) well plate will be used as the 2D surface control. In this study, GFPtransfected 231 (231-GFP) BCa cells will be used for cell culture. Since there is currently no
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approved targeted therapy for TNBC in clinical settings, a better understanding of the pathogenesis
of a TNBC cell line such as 231 is crucial to advancing therapy development [14].
Our hypothesis is that 231-GFP BCa cells cultured on 2 wt% CA scaffolds, with the lowest
stiffness, will show the highest cell proliferation. We do not expect differences in morphology
among the different groups of 3D porous CA scaffolds. We expect higher cell migration in
scaffolds with higher stiffness compared to ones with lower stiffness.
Since cancer progression is often accompanied by changes in cell behavior in response to
changes from the tumor microenvironment, understanding how the mechanical properties of CA
scaffolds affect the behavior of BCa cells could lead to the development of improved 3D BCa
tumor models. Tumor models that more closely depict the dynamic interactions between cancer
cells and their microenvironment could potentially enhance the study of disease pathology and
development of more effective BCa treatments.
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CHAPTER TWO: MATERIALS AND METHODS
Scaffold Fabrication
The 2 wt% CA scaffolds were produced by preparing the 2 wt% alginate and 2 wt%
chitosan solutions separately. The 2 wt% alginate solution was prepared by adding alginate to DI
water slowly, then soaking for 20 - 30 min before being mixed twice in a Thinky mixer for 3 min
at 2000 rpm. The 2 wt% chitosan solution was prepared by adding chitosan to 0.5 wt% acetic acid
solution. The chitosan solution was mixed twice in a Thinky mixer for 3 min at 2000 rpm. The
alginate and chitosan solutions were aged overnight at room temperature to allow for complete
dissolution of the polymers. Then, the alginate and chitosan solutions were mixed together twice
in a Thinky mixer for 5 min at 2000 rpm. The mixed CA solution was cast into molds and frozen
overnight at -20 °C. The scaffolds were freeze dried for 24 h or until they are dry. The scaffolds
were then sectioned into 2 mm thick disks using a razor blade. Next, the scaffolds were crosslinked
with 0.2 M CaCl2 solution for 20 min under vacuum. Finally, the scaffolds were sterilized with
70% ethanol under vacuum for 30 min in two 15 min sessions. In between the sessions, the 70%
ethanol solution were replaced with fresh 70% ethanol solution. Afterwards, the sterilized
scaffolds were washed with Dulbecco's phosphate buffered saline (DPBS) three times in a sterile
setting. The 4 and 6 wt% CA scaffolds were prepared with respective increases in chitosan and
alginate content, with 1 and 1.5 wt% acetic acid solution used for the chitosan solutions. Table 1
summarizes the components and their amounts used to produce each type of CA scaffold. All
sterilized CA scaffolds were soaked in fully supplemented media for 24 h at 37 °C before cell
seeding.
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Table 1. Components of alginate and chitosan solutions.

Alginate Solution
Wt %

Alginate

DI Water

Chitosan Solution
Chitosan

Acetic Acid

DI Water

2

2.084

100

2.084

0.5

99.5

4

4.167

100

4.167

1

99

6

6.25

100

6.25

1.5

98.5

Compression Testing
CA scaffold samples were cut to a size of 5 mm x 5 mm x 5 mm. Compression testing was
completed using the Shimadzu AGS-X Universal Electromechanical Tester. Wet samples were
compressed at a rate of 0.4 mm/min with a 500 N load cell (n = at least 6 per condition). Two types
of Young’s moduli, or stiffness, were determined from the stress vs. strain plots obtained by the
Trapezium X Universal Testing Software as shown in Figure 1. The first type is the bulk stiffness
obtained from the slope of the first linear region of the plots, indicating the stiffness associated
with compressing the pores of the scaffolds. The second type is the wall stiffness obtained from
the slope of the second linear region of the plots, indicating the stiffness associated with the
scaffold material after the pores have been compressed [28]. The stiffness values were calculated
using the Trapezium X Universal Testing Software.
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Figure 1. An example of a stress-strain plot obtained from a compression test.

Scanning Electron Microscopy Imaging
CA scaffolds (n = 3 per scaffold type) were imaged on the JEOL JSM-6480 SEM. The
scaffold samples were sputter coated with gold prior to imaging. The average pore size (µm) of
each CA scaffold type was calculated from the SEM images using the line intercept method
adapted from the American Society for Testing and Materials (ASTM) E4 standard for calculating
average grain size. Five horizontal lines of equal length were placed at regular intervals over the
image and the number of pores the measuring line crossed were counted. The pore size was
calculated with the following formula.
Pore size (µm) =

length of measuring line (µm)
number of pores measuring line crossed

Cell Seeding on Scaffolds
MDA-MB-231-GFP (231-GFP) BCa cells were cultured and expanded to 80% confluency
in T75 cell culture flasks in fully supplemented media (Dulbecco's Modified Eagle's medium
(DMEM) with 10% FBS, 1% penicillin-streptomycin, and 1% non-essential amino acids
(NEAA)), and incubated at 37 °C prior to cell seeding. 231-GFP BCa cells were detached from
T75 cell culture flasks by using Trypsin. Media was aspirated from T75 flasks leaving 231-GFP
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cells attached at the bottom surface of the flasks. 3 mL of Trypsin was added to each T75 flask
and flasks were incubated at 37 °C for 5 min. 2 mL of fully supplemented media was added to
each T75 flask to neutralize Trypsin. The flask surface with cells attached were washed with the
neutralized Trypsin solution several times to detach all cells. The neutralized Trypsin-cell solution
from each flask was collected in a 50 mL tube, which was centrifuged at 200 g for 10 min to get
the cell pellet. The supernatant was aspirated from the 50 mL tube leaving the cell pellet. Cells
were resuspended in fully supplemented media and seeded onto 2D surfaces and CA scaffolds in
12-well plates at 50,000 cells per sample. The samples were cultured in fully supplemented media
and at 37 °C with 5% CO2 in a humidified incubator. The samples were cultured for 7 days with
regular media changes.
Cell Number Analysis
The growth of BCa cells in 2D cultures and 3D CA scaffolds was assessed with Alamar
Blue assay (n = 4 per scaffold type) on day 3 and day 7. Cell culture media in samples was aspirated
and samples were washed one time with DPBS. 10% Alamar Blue solution in fresh cell culture
media was added to samples and the samples were incubated at 37 °C for 2 h. Alamar Blue
solutions was transferred from the samples to a black bottom 96-well plate and read with the
BioTek Cytation5 Cell Imaging Multi-Mode Reader at excitation wavelength of 570 nm and
fluorescent emission wavelength of 585 nm. The fluorescence results were compared to a standard
curve to determine cell population.
Cell Morphology Analysis
The cell morphology of BCa cells cultured on 2D surfaces and 3D CA scaffolds were
assessed (n > 50 per scaffold type) on day 1, 3, and 7 timepoints. Samples were fixed with 3.7%
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formaldehyde and imaged with the BioTek Cytation5 Cell Imaging Multi-Mode Reader using the
GFP filter at excitation wavelength of 490 nm and fluorescent emission wavelength of 510 nm on
day 1, 3, and 7 timepoints. Cellular morphology analysis was conducted using BioTek Gen5
Software on day 1, and 3 timepoints. Analysis parameters included circularity, size, area, and
perimeter. Circularity was calculated based on an ellipse formula where 1 equals a perfect circle.
Size was determined using an ellipse equation fit on the cell contour. Area was calculated based
on the number of pixels inside the cell contour. Perimeter was calculated by counting the edge
pixels along the cell boundary. Morphology analysis for day 7 cultures was not performed due to
the large number of cells in culture leading to noisy GFP signals picked up by the analysis software.
Cell Migration Analysis
BCa cell migration was assessed (n > 50 per scaffold type) at day 7 timepoint. Cells
cultured on 2D surfaces and 3D scaffolds were harvested by incubating the samples in Accumax
solution at room temperature for 15 min. The cells were washed off the scaffolds by pipetting the
Accumax solution on the scaffold surface 10 - 20 times. The Accumax solution from each sample
group were collected in a 50 mL tube with filled with 7 mL media and centrifuged at 200 g for 10
min to get the cell pellet. The supernatant was aspirated leaving the cell pellet. Cells were
resuspended in fully supplemented media, and seeded on glass-bottom Petri dishes filled with fully
supplemented media. A cell seeding solution density of 1 million cells/mL was used. A volume of
100 uL of seeding solution was added to each dish to achieve 100,000 cells/dish. Samples are
incubated overnight at 37 °C. Samples were rinsed with DPBS one time to remove unattached cells
from gels before migration experiment proceeded. 2 mL of fresh fully supplemented media was
added into each dish.
12

Samples were imaged using the ZEISS Cell Observer SD confocal microscope with a
motorized scanning stage. Brightfield and fluorescence images were taken at 20 magnification.
Time-lapsed images were acquired every 10 min for 3 h. Time-lapsed videos were analyzed and
single-cell migration velocity on each sample were determined using MATLAB and Cell Tracker.
Briefly, the positions of a cell at each specific timepoint were manually specified by clicking on
the centroid of the same cell in the images. The time interval between each image was specified as
10 min. The distance the cell traveled between timepoints was calculated by Cell Tracker using
the pixel size. The average cell migration speed for the single tracked cell was calculated by the
software.
Statistically Analysis
All data were statistically analyzed and presented as mean ± standard deviation of the
mean. A p-value of p < 0.05 was set as the statistical significance for all analysis of variance and
t-tests.
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CHAPTER THREE: RESULTS AND DISCUSSIONS
Scaffold Mechanical Properties
3D porous CA scaffolds were fabricated with varying concentrations to achieve a range of
Young’s moduli to recapitulate the stiffness changes the native cancer tumor microenvironment
issue undergoes throughout cancer progression. The 3D CA scaffolds underwent compression
testing in wet condition to better represent the scaffolds state in cell culture media. Compressive
testing yielded the bulk and wall Young’s moduli, or stiffness, as reported in Figures 2 and 3,
respectively. The bulk stiffness of 2 wt%, 4 wt% and 6 wt% CA scaffolds are 2.0 ± 0.1 Pa, 11.7 ±
1.1 Pa and 42.5 ± 0.1 Pa, respectively (Figure 2). The wall stiffness of 2 wt%, 4 wt% and 6 wt%
CA scaffolds are 64.0 ± 8.0 Pa, 2.365 ± 0.32 kPa and 3.30 ± 0.415 kPa, respectively (Figure 3).
There was significant difference in stiffness among all groups of CA scaffolds. This study focuses
primarily on the wall stiffness since it is associated with the scaffold material after the pores have
been compressed, indicating the stiffness that the cancer cells sense. The stiffness of normal breast
tissue ranges from a fraction of kPa to 3.25 ± 0.91 kPa [11], indicating that the 2 wt%, 4 wt%, and
6 wt% CA scaffolds all have stiffness that fall within the range of normal breast tissue stiffness.
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Figure 2. Bulk Young’s Modulus of CA scaffolds.

Figure 3. Wall Young’s Modulus of CA scaffolds.

In addition to fabricating CA scaffolds with various stiffnesses to simulate the BCa tissue
stiffness, scaffolds were also produced using a method that ensured a highly interconnected pore
network in the scaffolds as shown in the SEM images in Figure 4. The scaffold fabrication utilized
the freeze casting method, where the CA solution was frozen to separate the CA polyelectrolyte
complex (PEC) from the solvent, then sublimated, leaving behind the pores that were created by
the frozen solvent crystal [29]. The average pore sizes of 2 wt%, 4 wt%, and 6 wt% were calculated
15

to be 253.29 ± 52.45 µm, 209.55 ± 21.46 µm, and 216.83 ± 32.63 µm, respectively (Figure 5).
There is significant difference between the pore sizes of 2 wt% CA scaffolds compared to the rest
of the groups. Differences in pore size may be explained by difference in CA solution
concentrations since the pore structure of 3D polymer scaffolds depend on several parameters
including the concentration of the polymer solution [30].

Figure 4. SEM images of the CA scaffolds.
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Figure 5. Average pore sizes of the CA scaffolds.

Cell Proliferation
The growth of 231-GFP cells on the scaffolds was characterized at day 3 and day 7
timepoints using Alamar Blue. The CA scaffolds and 2D TCPS control were seeded with 231-GFP
and cultured for 7 days with regular media changes. 231-GFP cultured on 3D scaffolds had lower
cell numbers compared to those on 2D surfaces on both timepoints (Figure 6). The lower cell
number in 3D cultures was expected as cells in a 3D environment experience a limit in nutrients
and oxygen diffusion while cells in flat monolayers on 2D surfaces readily receive oxygen and
nutrients [5]. However, the absence of significant differences in cell number among the CA
scaffold groups at both timepoints was unexpected because the effect of ECM stiffness on cancer
cell growth has shown the rigidity-dependence growth of 231 cells with 4-5 fold increase in cell
number on stiffer substrates [22]. However, differences in the effect of matrix stiffness on 231 cell
proliferation between previous research and this project can be partially explained by the
difference in the chemistry of cell culture substrates. While the mentioned research used collagencoupled polyacrylamide gels, this project used porous CA scaffolds that lacked proteins such as
collagen serving as binding sites for cell surface integrins.
17

Figure 6. 231-GFP cell number at day 3 and day 7.

Cell Morphology
Fluorescence images of the cell cultures were taken to characterize the effect of ECM
stiffness on the morphology of 231-GFP cells at day 1, 3, and 7 timepoints. Figure 7 shows a visual
representation of the different cultures on day 1 and day 3. 2D cultures showed a stellate pattern,
while cells cultured in 3D scaffolds formed spheroids. This qualitative analysis was supported by
the quantification of 231-GFP morphology using cellular circularity. The circularity on day 1 for
231-GFP cells on 2D, 2 wt%, 4 wt%, and 6 wt% CA scaffolds were 0.352 ± 0.213, 0.491 ± 0.234,
0.521 ± 0.244, and 0.544 ± 0.218, respectively. The circularity on day 3 for 231-GFP cells on 2D,
2 wt%, 4 wt%, and 6 wt% CA scaffolds were 0.350 ± 0.209, 0.476 ± 0.238, 0.523 ± 0.245, and
0.532 ± 0.229, respectively. Cells cultured on 2D surfaces possessed significantly lower circularity
compared to those cultured in 3D CA scaffolds on both day 1 and day 3 timepoints (Figure 8A).
This observation is consistent with a 2015 study investigating the behaviors of 231 cells in 3D
porous scaffolds. In this study, 231 cells cultured in 3D porous PCL scaffolds formed tumor-like
masses while those on 2D surfaces remained well-spread [19].
18

Figure 7. Fluorescence images of the 231-GFP cultures at day 1 and day 3.
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Figure 8. 231-GFP cell morphology characterization at day 3 and day 7. (A) Circularity of 231-GFP cells. (B) Size of
231-GFP cells. (C) Area of 231-GFP cells. (D) Perimeter of 231-GFP cells.

Further quantification of morphology parameters such as size, area, and perimeter was
done on day 1 and day 3 (Figures 8B – 8D). 231-GFP cells cultured in 2 wt% CA possessed
significantly higher size, area, and perimeter, as compared to those cultured in 4 wt% and 6 wt%
CA scaffolds. More specifically, cellular size on day 3 for cells cultured in 2 wt%, 4 wt%, and 6
wt% were 21.952 ± 9.455 µm, 27.645 ± 22.726 µm, 17.322 ± 11.076 µm, and 17.204 ± 10.504
µm, respectively. Based on the size of single 231 cells to be 12.4 ± 2.1 µm in diameter [31], the
obtained results on cellular size indicated the presence of more cell clusters in the softest of the
CA scaffolds groups. A similar trend in the dependence of the formation of 231 cell clusters on
matrix stiffness was shown in a previous study where cells on softer polyacrylamide gel substrates
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stayed in clusters due to stronger cell-cell interaction, while those on stiff polyacrylamide gel
substrates showed single-cell adhesion due to stronger cell-matrix interaction [32].
The formation of cell clusters also affected cellular circularity of cells cultured on the
different 3D porous CA scaffold groups. Figure 8A also shows that cells on 2 wt% CA scaffolds
had a lower circularity compared to those on 4 wt% and 6 wt% CA scaffolds. Figure 9 supported
this analysis by showing high magnification images on day 7 of 2 wt% CA scaffolds with dense
cell clusters forming irregular shapes, hence the lower circularity, compared with 4 wt% and 6
wt% CA scaffolds with smaller clusters and more individual round cells.

Figure 9. Fluorescence images of the 231-GFP cultures at day 7.

Cell Migration
BCa cell migration speed is closely related to the progression of BCa from a benign state
to a more malignant, invasive state due to the stiffening of the ECM. The migration of 231-GFP
cells cultured on 3D porous CA scaffolds was analyzed. 231-GFP cells were detached from 3D
CA scaffolds and 2D control surfaces on day 7 and seeded onto glass-bottom Petri dishes for the
migration experiment. The average migration speed of 231-GFP cells cultured in 3D scaffolds was
calculated by tracking single cells for 3 h on time-lapse videos using Cell Tracker on MATLAB.
Figure 10 shows an example of this cell tracking process. The red dots show the position of the
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tracked cell at a timepoint. The red line connecting the dots together at 3 h estimated the path that
the cell traveled. The average cell migration speed was calculated by dividing the distance cell
traveled between two timepoints by the amount of time elapsed.

Figure 10. Single-cell tracking for migration speed determination.

The average cell migration speeds for 2D, 2 wt%, 4 wt%, and 6 wt% CA scaffolds were
0.321 ± 0.151 µm/min, 0.291 ± 0.141 µm/min, 0.338 ± 0.115 µm/min, and 0.413 ± 0.143 µm/min,
respectively. Significant differences were observed between 6% CA and the remaining of the
sample groups as indicated on Figure 11. The literature has shown that cancer cells sense the ECM
stiffness and respond by generating traction forces on their surrounding environment [26]. A study
done with glioma cells on polyacrylamide gels showed that average migration speeds for U373MG and U87-MG cells decreased significantly as culture substrate rigidity decreased [23]. While
the result of cells in 6 wt% CA scaffold possessing the highest migration speed among the CA
scaffold groups due to its stiffness was expected, the absence of difference in migration speed
between 2D, 2 wt% CA, and 4 wt% CA scaffolds despite the difference in substrate stiffness was
not expected. The lack of difference in cell migration speed between 2D and the 3D groups of 2
wt% and 4 wt% may be explained by the difference in the dimensions of the cell culture format.
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The added dimension in 3D culture platform as compared to 2D may have elicited other phenotypic
and genotypic cellular responses affecting migration speed that are beyond the scope of pure
traction forces. The lack of difference in cell migration speed between the 3D groups of 2 wt%
and 4 wt% despite significant difference in stiffness may be due to the observation that their
stiffness values both fall within the range for normal breast tissue as found in literature [11].

Figure 11. 231-GFP cell migration speed at day 7 timepoint.
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CHAPTER FOUR: CONCLUSION AND FUTURE WORK
In conclusion, this project demonstrates the influence of 3D porous CA scaffold stiffness
on the behavior of MDA-MB-231 breast cancer cells. The fabricated 2 wt%, 4 wt%, and 6 wt%
3D porous CA scaffolds had stiffness in the range of normal breast tissue and fibrograndular tissue.
The results showed increased average migration speed for cells in 6 wt% CA scaffolds compared
to those in scaffolds of lesser stiffness, indicating the dependence of 231-GFP migration speed on
3D substrate stiffness. The data also showed lower cellular circularity and higher cell size, area,
and perimeter for 231-GFP cultured in 2 wt% CA scaffolds compared to those in scaffolds of
higher stiffness, indicating the dependence of 231-GFP migration morphology on 3D substrate
stiffness. Findings from this project may contribute to future fabrication of 3D porous scaffolds
aiming to mimic the ECM of normal breast tissue and fibroglandular tissue to create a more
predictive model of BCa progression with varying ECM stiffness.
As discussed throughout the previous section, there were a few unexpected results such as
the lack of difference in cell growth among the 3D scaffold groups, and the lack of difference in
cell migration speeds between 231-GFP cells in 2 wt% and 4 wt% CA scaffolds. Some immediate
steps that can be taken following this project are further characterizing the proliferation of MDAMB-231 cells in 3D porous CA scaffolds by culturing cells over a time period longer than 7 days
and eliciting significant difference in migration speed by fabricating CA scaffolds with stiffness
that span the entire range of breast tissue from normal breast tissue stiffness of less than 1 kPa to
invasive IDC stiffness of over 42.52 kPa.
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